A growing body of research explores peptides that target cellular aging, telomere biology, mitochondrial function, and healthspan.
16 peptides commonly researched for this goal. Tap any card for the full guide.
A copper-carrying tripeptide with real cosmetic-industry backing. One of the few peptides on this list with legitimate topical clinical data.
Read the guideWidely considered the gentlest GH-releasing peptide in its class. Commonly paired with CJC-1295 in research stacks.
Read the guideA GHRH analog that comes in a long-acting (DAC) and short-acting (no-DAC/Mod GRF) form. The choice materially changes the risk/use profile.
Read the guideThe most 'clinically legitimate' GH secretagogue on this list. Formerly FDA-approved, now prescribed off-label at anti-aging clinics.
Read the guideA genuinely FDA-approved peptide (for visceral fat in HIV lipodystrophy) that's widely used off-label for general body composition.
Read the guideAn older, stronger GH-releasing peptide. More effective per dose than Ipamorelin, but with a rougher side-effect profile.
Read the guideThe original ghrelin-mimetic GHRP. Famous (or notorious) for making users very hungry.
Read the guideThe most potent common GHRP, with a unique secondary cardioprotective research angle.
Read the guideTechnically not a peptide, but it belongs in this catalog because it's almost always discussed in the same breath. An oral GH secretagogue with real blood-sugar tradeoffs.
Read the guideA mitochondrial-encoded 'exercise mimetic' peptide with strong lab-bench interest but very little human data yet.
Read the guideAn early-stage longevity-research peptide focused on protecting cells from stress-induced death. Almost entirely preclinical so far.
Read the guideOne of the few 'longevity peptides' with actual elderly-cohort human trial data behind it. From a specific, not-widely-replicated Russian research program.
Read the guideA high-profile mouse-study senolytic that made headlines for reversing signs of aging in animals. With zero human safety or efficacy data so far.
Read the guideA mitochondria-targeted peptide with real clinical-trial pedigree in rare mitochondrial diseases and heart failure.
Read the guideA thymus-derived immune peptide, often paired with Epithalon in Russian longevity research protocols.
Read the guideA genuinely common, well-tolerated cosmetic peptide already in a lot of skincare products on the market.
Read the guide"Longevity peptides" is a loose bucket covering a few very different mechanisms. The biggest group here is the growth-hormone secretagogues: Sermorelin, Tesamorelin, CJC-1295, Ipamorelin, and the GHRPs. They nudge your own pituitary to release more growth hormone, which is why they get grouped with anti-aging even though most were studied for body composition, not lifespan. Then there are the cellular and mitochondrial peptides. Epithalon targets telomere biology. SS-31 (Elamipretide) and MOTS-c work on mitochondrial function. Humanin and FOXO4-DRI sit further out on the research frontier. GHK-Cu rounds it out as the copper peptide with real topical cosmetic data.
Be honest about what "anti-aging" means with these compounds. The evidence is uneven. A few, like Sermorelin and Tesamorelin, have serious clinical pedigree, though for narrow approved uses. Most of the true longevity claims rest on animal studies, small cohorts, or a single research program that has not been widely replicated. This page is educational. It is not medical advice, and none of it tells you to run a protocol.
| Peptide | Category | Studied for | Evidence |
|---|---|---|---|
| GHK-CuCopper peptide | Healing & Recovery | Recovery & Healing, Skin & Hair | Extensive research |
| IpamorelinGH releasing peptide (GHRP) | Growth Hormone Secretagogues | Muscle Growth, Longevity | Extensive research |
| CJC-1295CJC-1295 with DAC | Growth Hormone Secretagogues | Muscle Growth, Longevity | Extensive research |
| SermorelinGHRH analog | Growth Hormone Secretagogues | Muscle Growth, Longevity | Extensive research |
| TesamorelinEgrifta | Growth Hormone Secretagogues | Muscle Growth, Longevity | Extensive research |
| GHRP-2GH releasing peptide (GHRP) | Growth Hormone Secretagogues | Muscle Growth, Longevity | Moderate research |
| GHRP-6GH releasing peptide (GHRP) | Growth Hormone Secretagogues | Muscle Growth, Longevity | Moderate research |
| HexarelinGH releasing peptide (GHRP) | Growth Hormone Secretagogues | Muscle Growth, Longevity | Moderate research |
| MK-677 (Ibutamoren)Non-peptide GH secretagogue | Growth Hormone Secretagogues | Muscle Growth, Longevity | Extensive research |
| MOTS-cMitochondrial-derived peptide | Metabolic & Longevity | Longevity, Energy & Metabolism | Moderate research |
| HumaninMitochondrial-derived peptide | Longevity & Cellular Health | Longevity, Cognitive Function | Limited research |
| EpithalonEpitalon | Longevity & Cellular Health | Longevity, Sleep | Moderate research |
| FOXO4-DRISenolytic peptide | Longevity & Cellular Health | Longevity | Limited research |
| SS-31 (Elamipretide)Mitochondrial peptide | Longevity & Cellular Health | Longevity, Energy & Metabolism | Moderate research |
| ThymalinThymic peptide | Immune | Immune Support, Longevity | Limited research |
| Matrixyl (Palmitoyl Pentapeptide-4)Signal peptide | Skin & Cosmetic | Skin & Hair, Longevity | Moderate research |
There is no single mechanism, which is the first thing to understand. The GH secretagogues work upstream of growth hormone and IGF-1, the signaling axis that naturally declines with age. Sermorelin and CJC-1295 mimic GHRH. Ipamorelin and the GHRPs mimic ghrelin. The idea is to restore a more youthful GH pulse rather than inject growth hormone directly. Tesamorelin is the standout here because it is genuinely FDA-approved, though for visceral fat in HIV lipodystrophy, not aging.
The cellular peptides aim at aging itself rather than a hormone. Epithalon is studied for its effect on telomerase and telomere length. SS-31 concentrates in mitochondria and is meant to protect energy production, which is why it has real trial history in rare mitochondrial disease and heart failure. MOTS-c is described as an exercise mimetic. FOXO4-DRI is a senolytic that aims to clear aged cells, and it made headlines in mice. Interesting mechanisms, but mechanism is not the same as a proven human outcome.
The honest ranking looks like this. Tesamorelin and Sermorelin have the strongest clinical footing, both tied to specific approved or formerly-approved uses. GHK-Cu has legitimate topical clinical data on the cosmetic side. Epithalon is unusual in that it has actual elderly-cohort human trial data behind it, but that data comes from a specific Russian research program that has not been broadly replicated, so treat it with caution. SS-31 (Elamipretide) has real trial pedigree, though in disease populations rather than healthy aging.
Everything else is earlier. MOTS-c has strong lab interest and very little human data. Humanin is almost entirely preclinical. FOXO4-DRI has essentially zero human safety or efficacy data. The gap between an exciting animal result and a durable human benefit is wide, and for most of these peptides it has not been crossed. Where a compound is preclinical, the marketing usually runs well ahead of the science.
There is no single best. It depends what you mean by anti-aging. For clinical legitimacy, Sermorelin and Tesamorelin lead, both tied to approved GH-axis uses. For topical skin data, GHK-Cu stands out. Epithalon draws the most direct longevity attention but rests on limited, unreplicated human data. Match the compound to the specific goal, not to hype.
Epithalon is one of the few longevity peptides with actual elderly-cohort human trial data, and it is studied for effects on telomerase and telomere length. But that evidence comes from a single Russian research program that has not been widely replicated, and lifespan extension in humans is a very high bar. The honest answer is that the claim is intriguing and unproven.
Safety varies a lot across this category. Some, like Tesamorelin and Sermorelin, have real clinical safety records for their approved uses. Others, like FOXO4-DRI and Humanin, have little to no human safety data at all. Research-grade peptides also carry purity and sourcing risks. This is educational information, not a safety clearance, and these are questions for a clinician.
GH secretagogues like Sermorelin, CJC-1295, and Ipamorelin push your own pituitary to release more growth hormone, working through an existing hormone axis. Cellular peptides like Epithalon, SS-31, and MOTS-c target aging mechanisms directly, such as telomeres and mitochondria. Different pathways, different evidence bases, often lumped together under the same anti-aging label.
GHK-Cu is a copper-carrying tripeptide with real cosmetic-industry backing, and it is one of the few peptides in this category with legitimate topical clinical data. It is studied for collagen support and skin quality. That makes it better evidenced for the skin side of anti-aging than most systemic longevity peptides, though topical results should not be confused with whole-body effects.
A few do, for narrow indications. Tesamorelin is FDA-approved for visceral fat in HIV lipodystrophy. Sermorelin was formerly approved and is now prescribed off-label. Most of the others, including Epithalon, MOTS-c, Humanin, and FOXO4-DRI, are research compounds without US approval for anti-aging. Approval for one use does not mean a compound is validated for longevity.
Educational information only. This is not medical advice. Peptide AI is an informational and tracking platform. Everything on this page is for general education. It is not a substitute for professional medical advice and is not a recommendation to use any compound. Many peptides listed here are research compounds the FDA has not approved for human use. Talk to a qualified, licensed healthcare provider before you start, change, or stop any protocol.
Peptide AI joins your doses, labs, and wearables so you can see which compounds actually move your numbers.